×
Viatris Inventory 2010-2024 | VTRS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Viatris inventory for the quarter ending September 30, 2024 was
$4.085B
, a
11.24% increase
year-over-year.
Viatris inventory for 2023 was
$3.47B
, a
1.41% decline
from 2022.
Viatris inventory for 2022 was
$3.52B
, a
11.52% decline
from 2021.
Viatris inventory for 2021 was
$3.978B
, a
27.31% decline
from 2020.
View More
Viatris Inventory 2010-2024 | VTRS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Viatris inventory for 2023 was
$3.47B
, a
1.41% decline
from 2022.
Viatris inventory for 2022 was
$3.52B
, a
11.52% decline
from 2021.
Viatris inventory for 2021 was
$3.978B
, a
27.31% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$91.4B
Cencora (COR)
$47.5B
DiDi Global (DIDIY)
$23.3B
Natera (NTRA)
$21.4B
ICON (ICLR)
$16.1B
Avantor (AVTR)
$13.4B
Revvity (RVTY)
$13.4B
CochLear (CHEOY)
$12.8B
BioMerieux (BMXMF)
$12.7B
Solventum (SOLV)
$11.6B
Medpace Holdings (MEDP)
$9.8B
Doximity (DOCS)
$9.6B
Charles River Laboratories (CRL)
$9.5B
HealthEquity (HQY)
$9B
Sonic Healthcare (SKHHY)
$8.8B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5.1B
Sotera Health (SHC)
$3.9B
Organon (OGN)
$3.8B
BrightSpring Health Services (BTSG)
$3.2B
Surgery Partners (SGRY)
$2.9B
PACS (PACS)
$2.6B
Concentras Parent (CON)
$2.6B
Ardent Health Partners (ARDT)
$2.4B
Premier (PINC)
$2.1B
Alignment Healthcare (ALHC)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GeneDx Holdings (WGS)
$2B
GoodRx Holdings (GDRX)
$1.6B
Teladoc Health (TDOC)
$1.5B